ACHE and Alzheimer disease: In addition, it has been described that elevated AChE concentrations could also trigger the systemic inflammation, key in T2DM and AD, representing an interesting therapeutic target for both diseases, which support previous studies that described the possible relationship between AD and metabolic alterations [20–22], stressing AD as a multifactorial disease.